Incyte Corp (NASDAQ:INCY)

Great product line for the speculative investor. The company carries a lot of debt that will be offset with an approved drug candidate. The growth from the potential product pipeline is the attractive aspect of this security. I don't have a crystal ball, but assuming the big pipeline drugs prove positive this is a high flyer and I'm putting some of my chips on INCY and their product pipeline....

Innovative drug pipeline for common diseases such as Diabetes

FOR A SMALL BIO COMP, IT HAS SOME GOOD LOOKING DRUGS THAT COULD BE COMING TO THE MARKET IN THE NEXT 2 TH 4 YEARS !!!!!! ALL WAYS LOOKING FOR GOOD SMALL BIO COMP THAT HAVE A GOOD PRODUCR PIPE LINE.

In the pipeline with good trials

Nice chart pattern, starting to get bullish on the longer term chart. Has to break 10.00, it's at 9.87 now.

As of close of business on 12/04/2007, this was a 1-star Morningstar stock that was trading at more than double it's Morningstar fair value.

Super management team with proven track record. Multiple promising drug candidates in pipeline.

Loads of insider buying, lots of recent good news -a catalyst stock

deep pipe,good crew

8

Mainly on the recommendaion of a freind in the Pharma industry who is overall down on the industry's prospects but who says that this company's prospects are exciting. No insider information implied, just based on his public knowledge assessments.

Besides that there is the contrarian in me. Biotech overall is way out of favor right now yet Big Pharma is increasingly wanting to let the small firms do the creative work and then either buy the product rights or the company when they hit one. (They are also farming out the testing to companies like Covance.) I like buying when others have been selling.

No idea just hoping it will.

7

very interesting pipeline and partnered with pfizer

looking for a breakthrough

INCY IS AN ALL OUT BUY WITH BOTH FISTS.
YOU WON'T SEE INCY UNDER $10 DOLLARS MUCH LONGER.
ALL STATS SAY YES, AND SURPRISE EARNINGS REPORT SENDS STOCK HIGHER.
ANOTHER GREAT STOCK COMPARED TO 'NSTK' THE HYPE STOCK WITH THE WORSE FUNDAMENTALS AND RATINGS ON THE OTC MARKET TODAY.
MAYBE THEY SHOULD MAKE A SPRAY MIST SO THAT CRAMER CAN APPEAR!
CRAMER ISN'T GOING TO RIGHT ON NSTK!
MANY WILL GET HURT.
INCY IS CHEAPER AND HAS A BETTER MANAGEMENT COMPANY. EARNINGS ARE BETTER TO.
BETTER TO INVEST IN 'INCY' AND GET ALL THE BELLS AND WHISTLES THAN INVEST IN A SHALLOW, HOLLOW, POOR FUNDAMENTAL COMPANY LIKE NSTK!

promising drugs in pipe line
Chart techs look good

.. we'll se about this one .. having second thoughts ..

Cutting edge pipeline based on fundamental concepts of immunology. While most of its pipeline are early phase, I think the diversity of its offerings significant exceed to company's current market cap.